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To the Editor: Vinnard et al. (1) 
reported that the risk factors associated 
with initial isoniazid resistance among 
patients with tuberculous meningitis 
in the United States during 1993–
2005 included young age (25–34 
years) and foreign birth (1). In a 
previous survey, conducted in Taiwan 
during 2000–2008, we found the rate 
of antituberculosis drug resistance 
to be lower for older patients than 
for younger patients (2); however, 
current information about the patient 
characteristics associated with 
isoniazid-resistant tuberculosis (TB) 
in Taiwan is lacking. Therefore, to 
determine the risk factors associated 
with initial isoniazid resistance among 
patients with TB in Taiwan, we 
conducted a retrospective study.
The study was conducted at the 
National Taiwan University Hospital, 
a 2,500-bed tertiary care center in 
northern Taiwan. We analyzed culture-
confi rmed Mycobacterium tuberculosis 
isolates obtained from hospitalized 
patients during January 2000–
December 2010. A nonduplicate isolate 
was defi ned as 1 isolate collected for 
evaluation from 1 patient who visited 
the hospital (as inpatient or outpatient). 
If multiple isolates were available 
from a patient, only the one fi rst 
isolated was analyzed. All specimens 
were processed and pretreated as 
described elsewhere (3). Patients with 
multidrug-resistant TB were excluded 
on the basis of evidence for differences 
in the epidemiology of isoniazid-
resistant (rifampin-susceptible) TB and 
multidrug-resistant TB (4). Immigrant 
populations in Taiwan are limited; 
therefore, we did not analyze the origin 
of the patients.
After excluding patients with 
multidrug-resistant TB, we analyzed 
4,289 nonduplicate isolates, of which 
3,842 (89.6%) were susceptible to 
isoniazid and the other 447 (10.4%) 
were resistant to isoniazid. In terms 
of demographic associations, patients 
34–<44 years of age were more 
likely than those >74 years of age 
to have an isoniazid-resistant strain 
(Table). In addition, patients with 
extrapulmonary TB were less likely 
than patients with pulmonary TB to 
be infected with isoniazid-resistant 
TB. We also identifi ed 34 patients 
with TB meningitis. After excluding 2 
patients with multidrug-resistant TB, 
we found that 31 patients (mean age 
56.6 years) had isoniazid-susceptible 
TB meningitis and a 50-year-old man 
had meningitis caused by isoniazid-
resistant TB.
Our results are in agreement with 
those reported in a previous study 
in the United States, which found 
that the rate of isoniazid resistance 
was lower for isolates from elderly 
patients (1,4). This phenomenon may 
be attributable to the reactivation of a 
dormant infection. Because isoniazid 
was introduced to Taiwan for the 
treatment of TB in 1952, elderly 
persons in Taiwan probably did not 
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receive isoniazid if their TB developed 
when they were young. In the present 
study, the resistant rate was lower for 
M. tuberculosis strains isolated from 
elderly persons than from younger 
adults. These fi ndings suggest that 
fi rst-line anti-TB medications still 
have good in vitro activity against M. 
tuberculosis strains in elderly patients.
In contrast to the study by Vinnard 
et al. (1), our results showed that 
isoniazid-resistant M. tuberculosis 
was signifi cantly less likely to be 
isolated from nonrespiratory than from 
respiratory specimens. The reasons for 
this fi nding are unclear. Continuous 
monitoring of antimicrobial drug 
resistance among M. tuberculosis 
isolates isolated from various body 
sites needs to be incorporated into any 
TB surveillance program.
Gathering data on drug resistance 
rates is a major aspect of the global TB 
control program. Clinicians must have 
knowledge of local epidemiology, and 
mycobacteriology laboratories should 
maintain up-to-date information on 
drug susceptibility test profi les of 
local M. tuberculosis isolates.
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To the Editor: Seahorses 
(Hippocampus guttulatus and H. 
hippocampus) with signs of tail rot 
disease (lethargy, lack of appetite, 
white spots on the skin, and necrotic 
tail lesions) were collected from 
aquaria at the Institute of Marine 
Research, Spain, during March 
2007 through May 2009 (online 
Appendix Figure, www.cdc.gov/
EID/content/17/9/101289-appF.
htm). Microscopic examination 
of cutaneous lesions after Ziehl-
Neelsen staining disclosed acid-
fast bacilli. Microbiologic analysis 
showed unidentifi ed Mycobacterium 
strains. Subsequently, we used PCR 
amplifi cation of repetitive bacterial 
DNA elements to group the strains (1). 
The results showed an identical PCR 
pattern for the strains; thus, we selected 
strain BFLP-6T for analysis. On the 
basis of phenotypic and genotypic 
data, we consider the unknown acid-
fast bacillus to represent a novel 
species of the genus Mycobacterium, 
for which the name M. hippocampi sp. 
nov. is proposed.
Extraction and amplifi cation of 
genomic DNA for 16S rRNA sequence 
analysis were conducted as described 
(2), and the RNA polymerase B (rpoB) 
gene was amplifi ed and sequenced 
as described by Adékambi et al. (3). 
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Table. Factors associated with isoniazid resistance among Mycobacterium tuberculosis







rate OR (95% CI) 
Patient age, y 
 <14 42 2 4.76 0.32 (0.08–1.23) 
 14 to <24 241 22 9.13 0.64 (0.42–1.07) 
 24 to <34 342 36 10.53 0.75 (0.48–1.18) 
 34 to <44 384 52 13.54 Reference 
 44 to <54 490 56 11.43 0.82 (0.55–1.23) 
 54 to <64 609 70 11.49 0.83 (0.57–1.22) 
 64 to <74 845 96 11.36 0.82 (0.57–1.17) 
 74 to <84 986 85 8.62 0.60 (0.42–0.87) 
 84 350 28 8.00 0.56 (0.34–0.90) 
Patient sex 
 F 1,356 128 9.44 0.85 (0.69–1.06) 
 M 2,933 319 10.88 Reference 
Pulmonary tuberculosis 
 No 772 56 7.25 0.63 (0.47–0.84) 
 Yes 3,517 391 11.12 Reference 
*OR, odds ratio; CI, confidence interval. 
